Microlep 22.5mg Injection

Microlep 22.5mg Injection consists of the active ingredient Leuprolide acetate. It belongs to the class of medicines called Gonadotropin Releasing Hormone (GnRH) agonists. This injection treats prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that usually lines the interior of the uterus grows outside of it), and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used for the treatment of premature puberty, which is characterized by early physical development in children due to hormonal imbalances. Do not receive this injection if you are allergic to Leupxl Depot 22.5mg or its ingredients, including Goserelin and Triptorlin. Before receiving this medicine, inform your physician if you have a liver or kidney impairment. Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not take this treatment if you are pregnant or planning to get pregnant. During the treatment, the existing symptoms may worsen due to the sex steroid increase in the body. Talk to your physician for more concerns. Report to your doctor if your child has a progressive brain tumor. Before starting the treatment, notify your doctor about your underlying medical conditions, such as diabetes, seizures, heart problems with chest pain, irregular heartbeats, depression, or are at increased risk of thinning of bones (osteoporosis). This medicine is not recommended for patients with abnormal vaginal bleeding. If you are a woman of childbearing age, use non-hormonal contraceptives while taking Microlep 22.5mg Injection. Report to your doctor if you are a man with urinary obstruction or had an operation to remove your testicles. Tell your doctor if you feel pressure on the spinal cord and experience urinary disorders and haematuria (blood in the urine).